Catalyst Pharmaceuticals (CPRX) pops 10% at the open, apparently sparked by a positive Seeking Alpha article highlighting upcoming Phase 2 data on its drug for treatment of addiction to cocaine and other addictive substances. Author Scott Matusow thinks CPRX could gap up similar to THLD, VRTX and SRPT after their recent data results.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs